• PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic Medication

    Nov 1, 2012, 00:00

  • PDB19 Estimating the Costs of Diabetes Mellitus- An Analysis in Malaysia

    Nov 1, 2012, 00:00

  • PSY37 Patient-Reported Outcome (PRO) Assessments in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer Therapies

    Nov 1, 2012, 00:00

  • PCV24 Economic Analysis of Bemiparin and Enoxaparin Used for Thrombosis and Embolism Prevention in Orthopedic Patients in Russia

    Nov 1, 2012, 00:00

  • PCN18 Economic Evaluation of CT Colonography (CTC) Introduction Into the Colorectal Cancer Screening Program in Japan

    Nov 1, 2012, 00:00

  • DB4 Patient-Reported Hypoglycaemia in Real-World Settings in Seven European Countries

    Nov 1, 2012, 00:00

  • PRS1 The Use of Montelukast and Neuropsychiatric Disturbances Among Pediatric Asthmatics- A Nested Case-Control Study

    Nov 1, 2012, 00:00

  • PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MI

    Nov 1, 2012, 00:00

  • PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel- Based on Decision Tree Model

    Nov 1, 2012, 00:00

  • PHP110 Real-World Diagnosis and Treatment Patterns of Iron Deficiency Anemia in China

    Nov 1, 2012, 00:00

  • PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UK

    Nov 1, 2012, 00:00

  • PCN43 Cost Assessment of Companion Diagnostics in Breast Cancer

    Nov 1, 2012, 00:00

  • PSS19 Economic Evaluation of Ranibizumab for the Treatment of Macular Edema Secondary to Branch and Central Retinal Vein Occlusion in Canada

    Nov 1, 2012, 00:00

  • PMD66 Health-Economic Analysis of the Systematic Use of Single-Hand Secured Huber Needles (Positive-Pressure) in French Hospitals

    Nov 1, 2012, 00:00

  • PCV55 A Cost-Effectiveness Analysis of Coralan® (Ivabradine) Plus Standard Care Versus Standard Care Alone in Chronic Heart Failure

    Nov 1, 2012, 00:00

  • PCN25 A Population-Based Prediction of Breast Cancer in Russian Federation- Analysis HER2-Status Groups for Target Treatment

    Nov 1, 2012, 00:00

  • PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal Surgeries

    Nov 1, 2012, 00:00

  • PHP54 Chemical Drug Price Index Study

    Nov 1, 2012, 00:00

  • PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Gree One Move Forward to Efficiency

    Nov 1, 2012, 00:00

  • PHP98 Patients Preferences Versus Physicians Judgment- Is There a Difference in Health Care Decision Making?

    Nov 1, 2012, 00:00

  • PHP43 How Will Health Care Reform in Russia Affect Drug Pricing and Reimbursement?

    Nov 1, 2012, 00:00

  • PMS1 Irrational Use of Steroids- A Warning for the Health Care System

    Nov 1, 2012, 00:00

  • PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia

    Nov 1, 2012, 00:00

  • PMS16 Economic Burden of Juvenile Idiopathic Arthritis in Russia

    Nov 1, 2012, 00:00

  • PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in Japan

    Nov 1, 2012, 00:00

  • PHS58 Change in Health-Related Quality of Life After Occpational Therapy in Community-Dwelling Dependent Elderly- A Randomised Controled Trial

    Nov 1, 2012, 00:00

  • PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma

    Nov 1, 2012, 00:00

  • PIN36 Six Years Observational Study of the Cost of Highly Active Antiretroviral Therapy and HIV/AIDS Control

    Nov 1, 2012, 00:00

  • PMD74 The Relationship Between Treatment Satisfaction and Health Status among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PMS69 Key Drivers for Pricing and Reimbursement for Biologic Drugs in France

    Nov 1, 2012, 00:00

  • PHP65 Quality of Care- Reference and Counter Reference from Family Physicians and Rheumatologists' Perspectives– A Pilot Study

    Nov 1, 2012, 00:00

  • PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market Research

    Nov 1, 2012, 00:00

  • PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic Review

    Nov 1, 2012, 00:00

  • PIN4 The Impact of Pharmacist-Led Antimicrobial Stewardship in Intensive Care Units in a Regional Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PCN127 Policy Maker, Please Carefully Consider Your Needs- Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?

    Nov 1, 2012, 00:00

  • PIH17 Cost Benefit Analysis on the Long Term Effects of in Vitro Fertilization (IVF) in Gree An Analysis Based on a Lifetime Model

    Nov 1, 2012, 00:00

  • PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PIN2 Estimating the Additive Effects of Length of Stay on Contracting Clostridium Difficile Infection

    Nov 1, 2012, 00:00

  • PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

    Nov 1, 2012, 00:00

  • PCV1 Angiotensin Receptor Blockers and the Risk of Myocardial Infarction- Network Meta-Analysis and Probability Ranking

    Nov 1, 2012, 00:00

  • PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)

    Nov 1, 2012, 00:00

  • PMS59 Impact of Comorbidities on Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis

    Nov 1, 2012, 00:00

  • PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PIH19 Cost Effectiveness of Premalex (Escitalopram) Compared to Sertraline for Treatment of PMDD (Premenstrual Dysphoric Disorder), Based Upon the CGI-S

    Nov 1, 2012, 00:00

  • PRS21 Cost-Effectiveness of Budesonide/Formoterol Versus Fluticasone/Salmeterol Based on Real-World Effectiveness in Patients With COPD

    Nov 1, 2012, 00:00

  • MA1 Utilization of Disease Modifying Agents in Multiple Sclerosis- Analysis From an Italian Administrative Database

    Nov 1, 2012, 00:00

  • PDB11 Efficacy of Exentaide in Type 2 Diabetes Mellitus in a Local Hospital in Taiwan- a Pilot Study

    Nov 1, 2012, 00:00

  • PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland

    Nov 1, 2012, 00:00

  • PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome- A Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2012, 00:00

  • PND56 Assessing the Quality of Life in a Spanish Population With Multiple Sclerosis- The Slims Study

    Nov 1, 2012, 00:00

  • PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach

    Nov 1, 2012, 00:00

  • PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease- Data From a Large Multi-Centre Australian Registry

    Nov 1, 2012, 00:00

  • PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma- A Systematic Review

    Nov 1, 2012, 00:00

  • PHS5 Assessing the Clinical and Economic Burden of United States Veteran Ankylosing Spondylitis Patients

    Nov 1, 2012, 00:00

  • PSY26 Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies in Multiple Myeloma and Lymphoma Patients in Czech Republic

    Nov 1, 2012, 00:00

  • PDB26 Effect of Diabetes Disease Management Programs Based on Bundled Payment on Curative Health Care Costs in the Netherlands

    Nov 1, 2012, 00:00

  • PCV30 Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease in the Uk

    Nov 1, 2012, 00:00

  • PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PHS3 Assessing the Survival Rates and Economic Burden of Prostate Cancer in the United States Veteran Population

    Nov 1, 2012, 00:00

  • PRM76 A Treatment Sequence Approach for Modelling Crohn's Disease

    Nov 1, 2012, 00:00

  • PDB60 Preliminary Results on the Reliability and Validity of the Worry Subscale of the Hypoglycaemic Fear Survey-II for Assessing the Impact of Fear for Hypoglycemia on the Health-Related Quality of Life of Type 2 Diabetes Mellitus Patients ...

    Nov 1, 2012, 00:00

  • PCV94 The Influence of Disease-Specific Symptoms on the Health-Related Quality of Life in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHP15 Comparison of Health Expenditures and Drug Expenditures in Two Western Balkan Countries

    Nov 1, 2012, 00:00

  • PIN86 Clinical and Economic Burden of Community Acquired Pneumonia in 7 Countries. A Comparison With Invasive Pneumococcal Disease

    Nov 1, 2012, 00:00

  • PSY38 Spontaneous and Probed Disease-Defining Concepts Identified Through Concept Elicitation Interviews in Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PMS19 Investigation of Comparative Clinical Outcomes Profiles and Cost Effectiveness of Four Classes of Anti Arthritic Drugs Using HAQ DI, DAS -28 and EQ5D3L in a Tertiary Care Hospital in Western India

    Nov 1, 2012, 00:00

  • PHP45 Relapse Prevention After Switching to Risperidone Long-Acting Ingection- 6 Months Mirror Image Study in Japan

    Nov 1, 2012, 00:00

  • PRS44 The Impact Made by the Continuity of Care for COPD Patients on Health Outcomes and Medical Cost in Korea, According to the National Health Insurance Database

    Nov 1, 2012, 00:00

  • PRM140 An Applied Comparison of Meta-Analysis Techniques Using Bacille Calmette Guerin Vaccine Studies

    Nov 1, 2012, 00:00

  • PCV23 Beta Blockers for Treatment of Chronic Heart Failure in Spain- Review of the Economic Evidence and Efficiency Analysis

    Nov 1, 2012, 00:00

  • PRS42 Current Position of ICS/LABA Combination Therapy in Asthma and COPD in Primary and Secondary Care in Germany – Delphi Consensus Research

    Nov 1, 2012, 00:00

  • PRM53 Can the Disutility of Allergic Rhinitis and Conjunctivitis Be Calculated From the Aggregated Total Symptoms Score?

    Nov 1, 2012, 00:00

  • PMS4 Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV93 Study of the Use of Quality of Life Questionnaires in Cardiac Diseases in Poland

    Nov 1, 2012, 00:00

  • PCV13 Are Statins Effective to Prevent First Non-Fatal Myocardial Infarction in Real Life in a Low-Risk Country? A Population-Based Case-Referent Study Using the PGRx Information System

    Nov 1, 2012, 00:00

  • PMS11 The Inpatient Costs and Their Predictors in Patients with Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PND3 Relapses Requiring Intravenous Steroids and Multiple Sclerosis-Related Hospitalizations- Findings From the Phase 3 Define and Confirm Studies

    Nov 1, 2012, 00:00

  • PRS7 The Effect of Chronic Obstructive Pulmonary Disease (COPD) on Health Status in Urban China

    Nov 1, 2012, 00:00

  • PGI3 Determination of Efficacy, Adverse Drug Reactions and Cost Effectiveness of Three Triple Drug Regimens for the Treatment of H. Pylori Infected Acid Peptic Disease Patients

    Nov 1, 2012, 00:00

  • PSY21 Cost-Effectiveness of Posaconazole Versus Fluconazole in the Prophylaxis of Invasive Fungal Infections in Patients With Graft-Versus-Host Disease (GVHD) in Turkey

    Nov 1, 2012, 00:00

  • PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

    Nov 1, 2012, 00:00

  • PMD65 The Cost Effectiveness of Hand Held Ultrasound Scanning for AAA in Elderly Subjects With a History of Smoking

    Nov 1, 2012, 00:00

  • PDB6 Predictors of Reaching HbA1C Goal in T2Dm Patients Using Dipeptidyl Peptidase-4 Inhibitors (DPP4Is) Combination Therapy- A Subgroup Analysis

    Nov 1, 2012, 00:00

  • PSY33 Item Reduction and Assessment of Measurement Properties of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)

    Nov 1, 2012, 00:00

  • PMH40 How do Patients Describe Their Depression? - Incorporating the Patient's Voice Into Instrument Development

    Nov 1, 2012, 00:00

  • PRM23 Cost-Effectiveness Versus Patient Acceptability- The Exemplar of CFS/ME

    Nov 1, 2012, 00:00

  • PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues- Leuprorelin, Goserelin, Triptorelin

    Nov 1, 2012, 00:00

  • PHP198 From Science to Servi The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research Unit

    Nov 1, 2012, 00:00

  • PDB10 Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany- Results From a Large Real-Life Cohort Study

    Nov 1, 2012, 00:00

  • PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis

    Nov 1, 2012, 00:00

  • PHP21 Does National Essential Medicine System Improve Rational Drug Use in Primary Health Care Facilities? An Empirical Study in Rural China

    Nov 1, 2012, 00:00

  • PIN4 Mixed-Treatment Comparison of the Efficacy and Safety of Antiretroviral Drugs Indicated for Treatment-Experienced HIV Patients

    Nov 1, 2012, 00:00

  • PHS62 Assessment of Patient Satisfaction With Chronic Treatment Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • DU4 Inappropriate Use of Drugs Influences Health Budget of Population

    Nov 1, 2012, 00:00

  • PHP108 Pattern of Antibiotics Usage in Malaysian Hajj Pilgrim

    Nov 1, 2012, 00:00

  • PMD68 Cost-Effectiveness of Sacral Neuromodulation in the Treatment of Idiopathic Wet Refractory Overactive Bladder in Italy

    Nov 1, 2012, 00:00

  • PHS86 A Population-Based Study of the Resource Utilization and Costs of Treating Resectable Non-Small Cell Lung Cancer

    Nov 1, 2012, 00:00

  • PHP162 Review of NICE's Technology Appraisal Recommendations

    Nov 1, 2012, 00:00

  • PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?

    Nov 1, 2012, 00:00

  • PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PND27 Assessment of Informal Care Provided to Patients With Multiple Sclerosis and Limitation of Personal Autonomy

    Nov 1, 2012, 00:00

  • PCN3 Quality-Adjusted Survival in Patients With Wild-Type (WT) KRASs Metastatic Colorectal Cancer (mCRC) Receiving First-Line Therapy With Panitumumab Plus FOLFOX Versus FOLFOX Alone

    Nov 1, 2012, 00:00

  • PCV14 Colesevelam for the Treatment of Hyperlipidemia- A Retrospective ‘Real-World' Analysis From an Integrated Health System

    Nov 1, 2012, 00:00

  • PHP6 Comparing the Effectivness of Different Educational Programs for Children on Appropriate Antibiotic Use

    Nov 1, 2012, 00:00

  • PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany

    Nov 1, 2012, 00:00

  • PDB32 Diabetic Foot Syndrome Hospitalization Costs in Poland

    Nov 1, 2012, 00:00

  • PCN7 A Systematic Review of the Heterogeneity of Treatment Effect in Ovarian Cancer (OC)—Are There Implications for Outcomes Research?

    Nov 1, 2012, 00:00

  • PCV38 Economic Evaluation of Anticoagulant Strategies in Interventional Treatment of Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • PIH34 Identifying Individuals with Different Time Preferences in Time Trade-Off Valuations of Hypothetical Health States- A Latent Class Analysis of the US EQ-5D-3L Valuation Data

    Nov 1, 2012, 00:00

  • PGI2 Infliximab Reduces the Risk of Surgical Interventions and Hospitalization in Patients With Inflammatory Bowel Disease

    Nov 1, 2012, 00:00

  • PCN79 Pharmacoeconomic Evaluation of Acute Myeloid Leukemia and MDS Syndromes (Intermediate and High Risk) Treatment With Azacitidine in the Russian Federation

    Nov 1, 2012, 00:00

  • PND23 Economic Burden of Illness for Persons With Spina Bifida (SB) in Germany

    Nov 1, 2012, 00:00

  • PDB1 Risk Factors for Hypoglycemia Among Veterans With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PGI35 Health-Related Quality of Life in Patients With Haemophilia and Inhibitors on Prophylaxis With Anti-Inhibitor Complex Concentrate- Results From the Pro-Feiba Study

    Nov 1, 2012, 00:00

  • PMD73 Quality of Life and Resource Use After Transcatheter Aortic Valve Implantation. Preliminary Results of an Observational Multicentre Study

    Nov 1, 2012, 00:00

  • PHP117 Study on the Health Insurance Coverage Among Poor and Disadvantaged Citizens

    Nov 1, 2012, 00:00

  • PDB23 Cost Effectiveness of Angipars™ in the Treatment of Diabetic Foot Ulcers in Iran

    Nov 1, 2012, 00:00

  • PND22 Descriptive Analysis of the Direct Costs of Relapsing-Remitting Multiple Sclerosis in the Mexican Setting

    Nov 1, 2012, 00:00

  • PMD47 Economic Evaluation of Reduced Futile 1st Line Therapy in Metastatic Renal Cell Carcinoma Patients Using Early Angiogenesis-Specific Imaging

    Nov 1, 2012, 00:00

  • CE3 Hyperbaric Oxygen Therapy for the Treatment Non-Neurological Soft Tissue Radiation Injuries- a Cost Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PHS14 Clinical and Economic Analysis of “MoliCare® Premium Extra Soft” Diapers Efficient Application for Dermatitis and Pressure Ulcers' Prophylaxis for Immobile Urinary-Incontinent Patients

    Nov 1, 2012, 00:00

  • PCV42 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Hip Replacement

    Nov 1, 2012, 00:00

  • PCN26 Health State Utilities for Relapsed/Refractory (Rel/Ref) Hodgkin'S Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL)- Asian Pacific Country Data

    Nov 1, 2012, 00:00

  • PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PIN37 The Economic Burden of Initial Empiric Antibiotic Failure on Health Care Resource Utilization for Hospitalized Patients With Complicated Intra-Abdominal Infections (cIAIs) in Greece

    Nov 1, 2012, 00:00

  • PMS54 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • PMS74 Application of Data Visualization Tool- Treatment Patterns of Veteran Patients With Ankylosing Spondylitis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PCN3 Improvement of the 3rd Generation Colorectal Cancer Gene Chip

    Nov 1, 2012, 00:00

  • PRS47 Analysis of New Prescriptions for Long-Acting β2-Agonists in Five European Countries in 2011

    Nov 1, 2012, 00:00

  • PMD3 Pre-Screening Tools- A Neglected Approach to Diagnose and Cut Cost Associated With Osteoporosis

    Nov 1, 2012, 00:00

  • PCN10 Examining the Use of Rescue Antiemetic Medication for Chemotherapy Induced Nausea and Vomiting in a Commercial Population

    Nov 1, 2012, 00:00

  • PSS13 Cost-Effectiveness of Specialized Treatment Based on Cognitive Behavioural Therapy Versus Usual Care for Tinnitus

    Nov 1, 2012, 00:00

  • PHP161 Integration of Value of Information Into the Decision Making Process in Ireland

    Nov 1, 2012, 00:00

  • PIH26 Social Impact of Adalimumab in the Italian Perspective

    Nov 1, 2012, 00:00

  • PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing?

    Nov 1, 2012, 00:00

  • PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

    Nov 1, 2012, 00:00

  • PHS29 Cost of Treating Patients With Obstructive Sleep Apnea/Hypopnea Sydrome in the Sotiria Chest Hospital in Greece

    Nov 1, 2012, 00:00

  • PDB70 Characteristics of Long-Acting Somatostatin (SSA) Use in Acromegaly in the Netherlands

    Nov 1, 2012, 00:00

  • QL1 EQ-5D-5L Valuation Project for the Spanish Population – A Descriptive Overview and Preliminary Results

    Nov 1, 2012, 00:00

  • PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PHS79 The Analysis of the Formulary Committees in Kazakhstani Regions

    Nov 1, 2012, 00:00

  • PHS47 Cost-Utility Analysis of Rotigotine in Restless Legs Syndrome from the NHS Scotland Perspective

    Nov 1, 2012, 00:00

  • PHS94 Involvement of CNS Specialists in Health Care Provision for Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)- New Data from Nordbaden, Germany, 2003 - 2009

    Nov 1, 2012, 00:00

  • PSY42 Effectiveness and Safety of Anti-TNF Agents in Treatment of Moderate to Severe Psoriasis Vulgaris- Results of Work Productivity and Daily Activity Impairment

    Nov 1, 2012, 00:00

  • PIN16 Tuberculosis Treatment Outcomes in Patients With and Without Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PSU8 Budget Impact Analysis of Anti-Bacterial Suture Use in Appendectomy Procedures in Spain

    Nov 1, 2012, 00:00

  • PND10 Economic Evaluation of Interferon âeta-1A Versus Interferon âeta-1B in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran

    Nov 1, 2012, 00:00

  • PMD19 Budget Impact Analysis of Balloon Sinuplasty Versus Classic Functional Endoscopic Sinus Surgery. Using a Budget Impact Model to Identify Country Specific Market Access Strategy

    Nov 1, 2012, 00:00

  • PMS15 An Economic Evaluation of Denosumab in the Treatment of Postmenopausal Osteoporosis in a Taiwanese Setting

    Nov 1, 2012, 00:00

  • PMH10 Patient Persistence With Buprenorhine/Naloxone Film and Tablet Formulations in the Treatment of Opioid Dependence in the United States- Results From a Large Privately Insured Retrospective Database

    Nov 1, 2012, 00:00

  • PRM102 Validation of the Russian Version of Schizophrenia Quality of Life Questionnaire (S-QoL)

    Nov 1, 2012, 00:00

  • PSY30 Cost-Effectiveness of Ustekinumab in the Management of Moderate-to-Severe Plaque Psoriasis in Mexico

    Nov 1, 2012, 00:00

  • PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany

    Nov 1, 2012, 00:00

  • PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008- A Population-Based Analysis Using Health Administrative Databases

    Nov 1, 2012, 00:00

  • PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

    Nov 1, 2012, 00:00

  • PHS81 Health Care Organizations/Services Clustering- Comparison of Several Techniques Using UK Data

    Nov 1, 2012, 00:00

  • PHP27 The Effect of Retirement on Mental Health

    Nov 1, 2012, 00:00

  • PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in Taiwan

    Nov 1, 2012, 00:00

  • PGI13 Vaccination Status Against Hepatitis B Among Healthy Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PHP35 Is There a Difference in Prescription Medication Utilization Between Aged Adults with and Without Disability in the United States?

    Nov 1, 2012, 00:00

  • PSY20 Infliximab Significantly Improves Symtoms and Quality of Life in Patients With Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PHP32 Analyzing the Utilities of Fluoroquinolones at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PND37 The Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) for the Treatment of Acute Epileptic Seizures in the UK; a Hybrid Model Solution

    Nov 1, 2012, 00:00

  • PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case

    Nov 1, 2012, 00:00

  • PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

    Nov 1, 2012, 00:00

  • PDB3 How Different Were They? A Treatment Pattern Analysis of United States Patients With Type 2 Diabetes Mellitus (T2DM) Initiating Injectable Therapy

    Nov 1, 2012, 00:00

  • PHS77 Cancer Network Pharmacists Perspective of the First Year of the Cancer Drugs Fund

    Nov 1, 2012, 00:00

  • PHS42 Cost-Effectiveness of Infant Vaccination With 10 and 13-Valent Pneumococcal Conjugate Vaccines in the Russian Federation

    Nov 1, 2012, 00:00

  • PMD11 The Cost of Poor Sample Quality- Assessing the Financial Impact of Sample Rejection and Recollection in Health Care Insitutions

    Nov 1, 2012, 00:00

  • PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients- A Study From Emergency Room of a Chest Hospital in Delhi, India

    Nov 1, 2012, 00:00

  • PIN54 Evaluation of Skin Tests in the Diagnostics of Tuberculosis Infection

    Nov 1, 2012, 00:00

  • PCN54 Economic Burden Associated With Pancreatic Cancer in Europe

    Nov 1, 2012, 00:00

  • PHP49 Down-Scheduling Medicines from Prescription to Over-the-Counter- Win-Win?

    Nov 1, 2012, 00:00

  • PHP147 Early Access Programmes (EAPs)- Review of the European System

    Nov 1, 2012, 00:00

  • PMD38 The Cost Burden of Unexplained Syncope in Five European Countries- A Database Analysis

    Nov 1, 2012, 00:00

  • PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients- A Population-Based Study

    Nov 1, 2012, 00:00

  • PHP15 The Impact of Orphan Drug Incentives on Innovation and Pricing in Niche Therapeutic Markets- A Systematic Review of the Literature

    Nov 1, 2012, 00:00

  • PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

    Nov 1, 2012, 00:00

  • PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With Constipation

    Nov 1, 2012, 00:00

  • PSY17 Estimating the Direct Costs of Patients Treated With Eltrombopag in the French Setting

    Nov 1, 2012, 00:00

  • PSY11 The Effect of Serum Albumin Level With Kabiven for Nutrition Support in a Regional Hospital

    Nov 1, 2012, 00:00

  • PMD35 Cost Analysis of an Implantable Loop Recorder, Reveal© XT, for the Diagnosis of Atrial Fibrillation in Patients Who Underwent Cryptogenic Stroke From the Perspective of a Tertiary Spanish Hospital

    Nov 1, 2012, 00:00

  • PRS4 Comparative Efficacy of Aclidinium Bromide 400 Mcg Bid Versus Tiotropium 18 Mcg and 5 Mcg QD as Maintenance Bronchodilator Treatment to Relieve Symptoms in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)- A Network Met ...

    Nov 1, 2012, 00:00

  • PRM156 How to Increase Patient Retention Rate During Their Participation in Longitudinal Studies

    Nov 1, 2012, 00:00

  • PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a Problem

    Nov 1, 2012, 00:00

  • HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan- is It Fair and Legitimate?

    Nov 1, 2012, 00:00

  • PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • PMS32 Cost-Efectiveness Analysis of Anti-Osteoporotic Therapy Among Korean Women With Postmenopausal Osteoporosis

    Nov 1, 2012, 00:00

  • PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices- A Useful Tool for Device Developers?

    Nov 1, 2012, 00:00

  • PCV84 Misdiagnosis and Mistreatment of ACE-Inhibitor Induced Cough Decreases Therapy Compliance

    Nov 1, 2012, 00:00

  • PIN72 Cost-Effectiveness Analysis of Palivizumab With Risk Factors for Respiratory Syncytial Virus Prevention

    Nov 1, 2012, 00:00

  • PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients

    Nov 1, 2012, 00:00

  • PND17 Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin Infusion in Treating Guillain-BarrÉ Syndrome

    Nov 1, 2012, 00:00

  • PND28 Health Care Costs of Multiple Sclerosis in Germany

    Nov 1, 2012, 00:00

  • PCN136 Expenditures on Orphan Drugs in Canada, Europe (EU5 + Belgium, Sweden and the Netherlands) and Australia in 2009

    Nov 1, 2012, 00:00

  • PMH42 Assessing Impacts of Major Depressive Disorder (MDD) on Cognitive Function

    Nov 1, 2012, 00:00

  • PCN23 Cost-Effectiveness Analysis of Gefitinib for Lung Cancer- A Population Based Study

    Nov 1, 2012, 00:00

  • PHP72 Making Money Work for Improvement of Patient Care- Success and Shortcomings of Pay-for-Performance Program in Taiwan

    Nov 1, 2012, 00:00

  • Dementia Care in the General Practice Setting- A Cluster Randomized Trial on the Effectiveness and Cost Impact of Three Management Strategies

    Sep 1, 2012, 00:00

  • State-Transition Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

    Sep 1, 2012, 00:00

  • Modeling Good Research Practices—Overview- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

    Sep 1, 2012, 00:00

  • The Utility Assessment Method Order Influences Measurement of Parents' Risk Attitude

    Sep 1, 2012, 00:00

  • A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the Patient Group and Health Care Professional Group in South Korea

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Sep 1, 2012, 00:00

  • Dynamic Transmission Modeling- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

    Sep 1, 2012, 00:00

  • An Evaluation Framework for Funding Drugs for Rare Diseases

    Sep 1, 2012, 00:00

  • Conceptualizing a Model- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2

    Sep 1, 2012, 00:00

  • Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families- Observations from the Dosing Observational Study in Hemophilia

    Sep 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada

    Sep 1, 2012, 00:00

  • Model Parameter Estimation and Uncertainty- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

    Sep 1, 2012, 00:00

  • Matching-Adjusted Indirect Comparisons- A New Tool for Timely Comparative Effectiveness Research

    Sep 1, 2012, 00:00

  • Model Transparency and Validation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

    Sep 1, 2012, 00:00

  • Multicriteria Decision Analysis for Including Health Interventions in the Universal Health Coverage Benefit Package in Thailand

    Sep 1, 2012, 00:00

  • Relative Effectiveness Assessment of Pharmaceuticals- Similarities and Differences in 29 Jurisdictions

    Sep 1, 2012, 00:00

  • Copyright/Subscription

    Sep 1, 2012, 00:00

  • Innovation and the Burden of Disease—Reply to Letter to the Editor by Catalá-López et al

    Sep 1, 2012, 00:00

  • Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies

    Sep 1, 2012, 00:00

  • Creating Models That Meet Decision Makers' Needs- A US Payer Perspective

    Sep 1, 2012, 00:00

  • Costs of Adverse Drug Events in German Hospitals—A Microcosting Study

    Sep 1, 2012, 00:00

  • Table of Contents

    Sep 1, 2012, 00:00

  • The View of a Model user on the ISPOR-SMDM Modeling Good Research Task Force Report

    Sep 1, 2012, 00:00

  • FDA Actions Against Health Economic Promotions, 2002–2011

    Sep 1, 2012, 00:00

  • Letter from the Editors

    Sep 1, 2012, 00:00

  • Evaluating New Health Technologies and Disease Burden in Developed Countries

    Sep 1, 2012, 00:00

  • Editorial Board

    Sep 1, 2012, 00:00

  • Modeling using Discrete Event Simulation- A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

    Sep 1, 2012, 00:00

  • Orthopaedic Trauma Care in Haiti- A Cost-Effectiveness Analysis of an Innovative Surgical Residency Program

    Sep 1, 2012, 00:00

  • Quality-of-Life Impact of Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer Patients

    Sep 1, 2012, 00:00

  • Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response

    Sep 1, 2012, 00:00

  • Development of a Decision-Analytic Model for the Application of STR-Based Provenance Testing of Transrectal Prostate Biopsy Specimens

    Sep 1, 2012, 00:00

  • The Inclusion of Informal Care in Applied Economic Evaluation- A Review

    Sep 1, 2012, 00:00

  • Instructions for Authors

    Jul 1, 2012, 00:00

  • Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care- The Case of Follow-Up Strategies after Breast Cancer Treatment

    Jul 1, 2012, 00:00

  • Erratum

    Jul 1, 2012, 00:00

  • Does Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care Safety

    Jul 1, 2012, 00:00

  • How Do Insured Perceive Their Financial Security in the Event of Illness?—A Panel Data Analysis for Germany

    Jul 1, 2012, 00:00

  • Economic Evaluation and the Jordan Rational Drug List- An Exploratory Study of National-Level Priority Setting

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas

    Jul 1, 2012, 00:00

  • The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

    Jul 1, 2012, 00:00

  • The Maximum Willingness to Pay for Smoking Cessation Method among Adult Smokers in Mexico

    Jul 1, 2012, 00:00

  • Modeling the Risks and Benefits of Depression Treatment for Children and Young Adults

    Jul 1, 2012, 00:00

  • Cost-Effectiveness Analysis of the Bivalent Compared with the Quadrivalent Human Papillomavirus Vaccines in Taiwan

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ-5D Questionnaire Mapping Algorithm

    Jul 1, 2012, 00:00

  • Editorial Board

    Jul 1, 2012, 00:00

  • Financial Risk-Sharing in Updating the National List of Health Services in Israel- Stakeholders' Perceived Interests

    Jul 1, 2012, 00:00

  • Valuing the Extended Role of Prescribing Pharmacist in General Practice- Results from a Discrete Choice Experiment

    Jul 1, 2012, 00:00

  • Whose Values in Health? An Empirical Comparison of the Application of Adolescent and Adult Values for the CHU-9D and AQOL-6D in the Australian Adolescent General Population

    Jul 1, 2012, 00:00

  • Development of a Database of Instruments for Resource-Use Measurement- Purpose, Feasibility, and Design

    Jul 1, 2012, 00:00

  • Improving the Measurement of QALYs in Dementia- Some Important Considerations

    Jul 1, 2012, 00:00

  • Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries- How Much Could Be Saved?

    Jul 1, 2012, 00:00

  • Inverse Probability Weighted Least Squares Regression in the Analysis of Time-Censored Cost Data- An Evaluation of the Approach Using SEER-Medicare

    Jul 1, 2012, 00:00

  • Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ5D Mapping Algorithm—Reply to Letter to the Editor by David Cella, Irina Proskorovsky, and Feng Pan

    Jul 1, 2012, 00:00

  • Interim Scoring for the EQ-5D-5L- Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

    Jul 1, 2012, 00:00

  • Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales- A Cost-Utility Analysis

    Jul 1, 2012, 00:00

  • Validation of the UFS-QOL-Hysterectomy Questionnaire- Modifying an Existing Measure for Comparative Effectiveness Research

    Jul 1, 2012, 00:00

  • Time Trade-Off and Ranking Exercises Are Sensitive to Different Dimensions of EQ-5D Health States

    Jul 1, 2012, 00:00

  • Deriving Input Parameters for Cost-Effectiveness Modeling- Taxonomy of Data Types and Approaches to Their Statistical Synthesis

    Jul 1, 2012, 00:00

  • Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States

    Jul 1, 2012, 00:00

  • Willingness to Pay for Prostate Cancer Treatment among Patients and Their Family Members at 1 Year After Diagnosis

    Jul 1, 2012, 00:00

  • Heterogeneous Effects of Health Insurance on Out-of-Pocket Expenditure on Medicines in Mexico

    Jul 1, 2012, 00:00

  • Table of Contents

    Jul 1, 2012, 00:00

  • Copyright/Subscription

    Jul 1, 2012, 00:00

  • Response to Comments on Mulhern et al., “Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis”

    Jul 1, 2012, 00:00

  • PHP15 What Price do we Pay for Repurposing Medicines for Rare Diseases?

    Jun 1, 2012, 00:00

  • PIN11 Costs of Adverse Events Among Patients With Human Immunodeficiency Virus Treated With Non-Nucleoside Reverse Transcriptase Inhibitors

    Jun 1, 2012, 00:00

  • PDB31 Targeted Cost Saving Strategies in Diabetes Prevention Using Risk Stratification

    Jun 1, 2012, 00:00

  • PRM27 A Method of Projecting Future Co-Morbidity Prevalence and Health Service Demand in the United Kingdom Population Using the Health Improvement Network (THIN)

    Jun 1, 2012, 00:00

  • PMS63 Treatment with Infliximab Improves the Quality of Life of Rheumatoid Arthritis Patients in China

    Jun 1, 2012, 00:00

  • PIN46 The Effect of Anemia on Health Status and Work Productivity Among Treated Hepatitis C Patients

    Jun 1, 2012, 00:00

  • PMH66 Growth in Antidepressant Use in 10 Countries in the Last Decade

    Jun 1, 2012, 00:00

  • PHP35 Determinants of Participation in Mammography Screening in Taiwan

    Jun 1, 2012, 00:00

  • PIH77 Annual Overall and Epilepsy-Related Health Care Utilization in Adult Epilepsy Patients in the United States

    Jun 1, 2012, 00:00

  • PSY3 Adverse Events Associated With Anti-TNF-Alpha- Agents- A Pharmacovigilance Study

    Jun 1, 2012, 00:00

  • PRS38 A Survey of Asthma Management Programs in Managed Care Organizations

    Jun 1, 2012, 00:00

  • PDB98 Treatment Patterns and Treatment Restrictions of Patients With Type II Diabetes Receving Care From Home Health Care Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the United States

    Jun 1, 2012, 00:00

  • PMD39 Projection of Health Economics Benefits of Continuous Glucose Monitoring Versus Self Monitoring of Blood Glucose in Type 1 Diabetes, in Sweden

    Jun 1, 2012, 00:00

  • PSU39 Identification of Bariatric Surgical Procedures, Comorbidities and Adverse Events in Payor Data

    Jun 1, 2012, 00:00

  • PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United States

    Jun 1, 2012, 00:00

  • PIN49 Patient Reported Quality of Life Following Antiretroviral Therapy in a Nigerian Hospital

    Jun 1, 2012, 00:00

  • PDB55 Estimating the Cost-Effectiveness of Premixed Analog Insulin Versus Long Acting Analog Basal Insulin and Premixed Human Insulin in the Management of Type 2 Diabetes- A Long Term Analysis in the United Kingdom (UK)

    Jun 1, 2012, 00:00

  • PSY8 Application of Data Visualization Tool- Treatment Patterns of Medicare Patients With Ankylosing Spondylitis who Initiated Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PMH53 Measuring Real World Outcomes by Incorporating PRO Data Collection into Patient Access Support Programs

    Jun 1, 2012, 00:00

  • RM3 Antipsychotic Use and Risk of All-Cause Mortality in Elderly Dual Eligible Beneficiaries

    Jun 1, 2012, 00:00

  • PRM23 Proqolid Database- Where Are We Ten Years After Its Launch?

    Jun 1, 2012, 00:00

  • PMH46 Examining the Differences Between Patients Treated for Major Depressive Disorder Compared to Those Who do not Realize They Have Major Depressive Disorder

    Jun 1, 2012, 00:00

  • PSU29 The Importance of Medical Appointments After Roux-en-Y Gastric Bypass in Morbid Obese Patients- Association Between Adherence to Medical Follow-Up Visits and the Bariatric Analysis and Reporting Outcome System (BAROS) Score Based on a ...

    Jun 1, 2012, 00:00

  • PIN35 Decision Analysis Model Evaluating the Cost-Effectiveness of Fidaxomicin and Vancomycin in the Treatment of Clostridium Difficile Infection (CDI) from a Hospital Perspective

    Jun 1, 2012, 00:00

  • PMH19 Combination Utilization Patterns and Treatment Predictors in ADHD in a Commercially Insured Population

    Jun 1, 2012, 00:00

  • PUK8 Nocturia and the Risk of Falls, Fractures, and Sleep Disturban a Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease- a Systematic Review and Meta Analysis of Randomized Controlled Trials

    Jun 1, 2012, 00:00

  • PHP47 The Economic Impact of a Cost-Effectiveness Threshold on the Innovative Drug Expenditure in Qatar

    Jun 1, 2012, 00:00

  • PMH10 Functional Outcome Measures- A Powerful Tool to Demonstrate Treatment Success in Schizophrenia

    Jun 1, 2012, 00:00

  • PIN37 Cost-Effectiveness of Treatment Initiation With Ritonavir-Boosted Atazanavir (ATV/R) and Lopinavir (LPV/R) in Treatment-NaÏve HIV Patients at Different CD4 Levels at Baseline

    Jun 1, 2012, 00:00

  • PHP61 The Financial Impacts of Pharmacist Intervention in Inpatient Department of a Local Hospital in Taiwan

    Jun 1, 2012, 00:00

  • PMH36 An Economic Evaluation of Screening for Dementia in South Korea

    Jun 1, 2012, 00:00

  • PCN32 Comparing Health Care Resource Use, Costs and Adverse Events Among Lung Cancer Patients Treated With Standard Chemotherapy With or Without an Angiogenesis Inhibitor- A Retrospective Database Study

    Jun 1, 2012, 00:00

  • PCV44 Financial Impact of Bleeding Events on Total Knee and Hip Replacements in the Argentinean Health Care System

    Jun 1, 2012, 00:00

  • PSU26 Cost-Utility Analysis of Bariatric Surgery for the Treatment of Obese Patients in South Korea

    Jun 1, 2012, 00:00

  • PHP38 Out-of-Pocket Drug Expenditure Among Users of the Ambulatory Care Services at the Mexican Institute of Social Security (IMSS)

    Jun 1, 2012, 00:00

  • PCN16 Design and Rationale of the Multiple Myeloma Preamble Study- A Prospective, Non-Interventional, Multi-Center Cohort Study

    Jun 1, 2012, 00:00

  • PSY67 Psychometric Validation of the Pain Impact Questionnaire Revised With a 1-Week Recall

    Jun 1, 2012, 00:00

  • PCV90 The Quality of Anticoagulation Therapy in Patients with Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PRM49 How to Present the Probability of Being the Best Treatment in the Context of a Bayesian Network Meta-Analysis of Parametric Survival Curves?

    Jun 1, 2012, 00:00

  • PHP30 The Bittersweet Success of Orphan Drugs

    Jun 1, 2012, 00:00

  • PSY62 Predictors of Pain Medication Selection Among Patients Diagnosed With Chronic Lower Back Pain

    Jun 1, 2012, 00:00

  • PMH57 Cross-Country Comparisons of Adults with Major Depressive Disorder

    Jun 1, 2012, 00:00

  • PCV124 Combining Electronic Health Records and Patient-Reported Information in the UK- Preliminary Results from Wasps (Wales Sail + Pro Study)

    Jun 1, 2012, 00:00

  • PND45 Mobility Impairment and Health-Related Quality of Life in Multiple Sclerosis Patients

    Jun 1, 2012, 00:00

  • PIN4 Efficacy and Safety of the Combination Tenofovir (TDF)/Emtricitabina (FTC) + Efavirenz (EFV) in Treatment of Naive Adult Patients With HIV-1 Infection- A Systematic Review

    Jun 1, 2012, 00:00

  • PND54 Short and Long-Term Variations in All Cause Health Care Utilization and Costs for Newly Diagnosed Multiple Sclerosis Patients Enrolled in Either Medicaid HMO or Commercial HMO

    Jun 1, 2012, 00:00

  • PHP101 Legal Impact of Pharmaceutical Pricing in the German Statutory Health Insurance System

    Jun 1, 2012, 00:00

  • PHP77 Technological Intervention- Nurses' Perception Regarding Performance Obstacles and Ease of Work

    Jun 1, 2012, 00:00

  • PND3 Indirect Treatment Comparison (ITC) Analysis of Therapies That are Often Considered for Treatment-Experienced Patients With Relapsing-Remitting Multiple Sclerosis

    Jun 1, 2012, 00:00

  • CE4 A Framework for Stakeholder Engagement in Comparative Effectiveness Research

    Jun 1, 2012, 00:00

  • PCN85 Economic Evaluation in the Treatment of Advanced and/or Metastatic Gastric Cancer From the Perspective of the Public Health System in Mexico

    Jun 1, 2012, 00:00

  • PCN115 Patterns of Care in Patients With Myelodysplastic Syndromes Treated With Hypomethylating Agents

    Jun 1, 2012, 00:00

  • PCV107 Impact of Medication Therapy Management (MTM) on Improving Diabetes Care- A Difference-in-Differences Approach

    Jun 1, 2012, 00:00

  • PCN73 Economic Evaluation of Antithrombotic Therapies in Patients With Cancer in Mexico

    Jun 1, 2012, 00:00

  • PMS68 Clinical and Economic Outcomes Associated with Teriparatide Adherence in Medicare Part D Recipients- A Retrospective Cohort Study

    Jun 1, 2012, 00:00

  • PCN154 Challenges Posed by Patient Crossover for Cost-Effectiveness Analysis of Oncology Products- A Case Study in Metastatic Pancreatic Cancer

    Jun 1, 2012, 00:00

  • PCV121 Using International HTA Guidelines to Inform UK Health Care Decision-Making- A Case Study of Ticagrelor in Combination with Low-Dose Aspirin for the Treatment of Acute Coronary Syndromes

    Jun 1, 2012, 00:00

  • PIN65 The Changing Nature of HIV in the Past 5 Years- Implications for Economic Modeling

    Jun 1, 2012, 00:00

  • PRS49 All-Cause 30-Day Readmissions for Matched Inpatients with Copd Receiving Nebulized Short-Acting or Long-Acting Beta Agonists

    Jun 1, 2012, 00:00

  • PDB69 the Impact of Nocturnal Hypoglycemic Events on Functioning, Well-Being and Diabetes Management

    Jun 1, 2012, 00:00

  • PSU40 Six Years of Cardiac Database Management- The Impact on Clinical Practice

    Jun 1, 2012, 00:00

  • PSS30 Dosing Patterns and Health Care Provider Interactions for Psoriasis Patients Treated with Ustekinumab

    Jun 1, 2012, 00:00

  • PCN61 Cost-Effectiveness of Sunitinib + Best Supportive Care for the Treatment of Unresectable Pancreatic Neuroendocrine Tumors in Mexico

    Jun 1, 2012, 00:00

  • PCN88 Cost-Effectiveness Analysis of Plerixafor for Stem Cell Mobilization for Poor Mobilizers in Canada

    Jun 1, 2012, 00:00

  • PSU20 Hospital Costs of Gastrointestinal Strictures Following Laparoscopic Bariatric Surgery Procedures Utilizing Circular Staplers

    Jun 1, 2012, 00:00

  • PIN61 Bacteriology and Inappropriate Empiric Therapy in Mixed Complicated Skin and Skin Structure Infections

    Jun 1, 2012, 00:00

  • PRS5 Co-Morbid Depression and Its Impact on Health Care Expenditure among Individuals with Asthma

    Jun 1, 2012, 00:00

  • PDB46 Direct Medical Costs of Treating Diabetes Related Complications in Mexico

    Jun 1, 2012, 00:00

  • PMH39 Impact of Adherence to Anti-Depressant Medication on Short-Term Disability Costs in an Employer Population

    Jun 1, 2012, 00:00

  • PSY39 Dosing and Refill Compliance in Ankylosing Spondylitis Patients Treated With Golimumab

    Jun 1, 2012, 00:00

  • PCN31 Economic Evaluation of Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) in the Brazilian Public Health Care System (SUS)

    Jun 1, 2012, 00:00

  • PIH5 Systematic Review Comparing the Efficacy of the 5-Alpha Reductase Inhibitors (5-Aris) Dutasteride and Finasteride in the Treatment of Benign Prostatic Hyperplasia (BPH)

    Jun 1, 2012, 00:00

  • PMD29 The Cost-Effectiveness of Diagnostic Sigmoidoscopy Before Colonoscopy in 40 to 49-Year-Old Symptomatic Patients

    Jun 1, 2012, 00:00

  • PCN18 Assessing the Clinical and Economic Burden of Veteran Breast Cancer Patients in the United States

    Jun 1, 2012, 00:00

  • CN4 Total Health Care Costs for Colorectal Cancer Patients Following Metastatic Diagnosis

    Jun 1, 2012, 00:00

  • PCN108 Review of the Content Validity of the Patient Reported Outcome Measures Used in Patients With Brain Metastases

    Jun 1, 2012, 00:00

  • PCV11 Patient Characteristics and Comorbidities of Patients with Atrial Fibrillation in Japan

    Jun 1, 2012, 00:00

  • PDB66 Instruments Measuring Treatment Adherence and Compliance in Diabetes Mellitus- a Literature Review

    Jun 1, 2012, 00:00

  • PIN12 Cost Analysis of Rilpivirine Versus Efavirenz for Treatment of Human Immunodeficiency Virus (HIV)

    Jun 1, 2012, 00:00

  • PCN17 Chemotherapy Treatment and Impact of Second Line Chemotherapy on Overall Survival (OS) in Metastatic Castrate Resistant Prostate Cancer (CRPC) in Southeastern Oncology Community Practice

    Jun 1, 2012, 00:00

  • PMS41 Persistency with Subcutaneous Anti-TNF Therapy for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Patients

    Jun 1, 2012, 00:00

  • PSU2 Relationship Between Medical Co-Morbidities and Hospitalization Following Elective Total Knee Arthroplasty (TKA)

    Jun 1, 2012, 00:00

  • PHP83 Community Health Workers- A Literature Review in Some Countries of South America

    Jun 1, 2012, 00:00

  • PCN99 Preference-Based Estimates of the Health Utility Impacts of Breast Cancer in Women Ages 18-44 in the United States

    Jun 1, 2012, 00:00

  • PIH39 Eliciting Preferences to the EQ-5D-5L Health States- Discrete Choice Experiment or Multiprofile Case of Best-Worst Scaling

    Jun 1, 2012, 00:00

  • PHP112 Investment and Disinvestment of Health Technologies- The Need for Two Cost-Effectiveness Thresholds

    Jun 1, 2012, 00:00

  • PMD14 Estimating the Economic Burden of Atrial Fibrillation in Selected Developing Countries

    Jun 1, 2012, 00:00

  • PDB11 Health Outcomes of Initiating Basal Analog Insulin via Disposable Pens Among Patients With Type-2 Diabetes in a National Managed Care Plan in the United States

    Jun 1, 2012, 00:00

  • PMD57 New Approaches for Graphing Probabilistic Patient-Relevant Health Outcomes- The Case of Renal Denervation for Resistant Hypertension

    Jun 1, 2012, 00:00

  • PMS10 The Cost of Hospitalisation for Knee Osteoarthritis in France in 2010

    Jun 1, 2012, 00:00

  • PMS14 Health Care Costs and Opioid Use among Patients with Osteoarthritis Initiating Duloxetine Versus Other Treatments

    Jun 1, 2012, 00:00

  • PSS1 Relieving the Pruritus of Atopic Dermatitis- A Meta-Analysis

    Jun 1, 2012, 00:00

  • PUK34 Validation of ICD-9 Codes for the Identification of Patients with Stage 3-5 Chronic Kidney Disease in Administrative Claims Data

    Jun 1, 2012, 00:00

  • PMH60 Health-Related Quality of Life (HRQOL) among Survivors 8 Months and 3 Years After Sichuan 2008 Earthquake in China

    Jun 1, 2012, 00:00

  • PHP86 Analysis of Factors Influencing Drugs Prescription Decision Making in Ukraine

    Jun 1, 2012, 00:00

  • PGI20 Pre- to Post-Diagnosis Increase in Utilization and Costs of Chronic-Use Medications and Other Medical Resources in Managed Care Enrollees with Diverticulitis

    Jun 1, 2012, 00:00

  • PIH60 Speaking of PROs- Towards Finding a Common PROse for Improving Communication about Health-Related Quality of Life Concepts

    Jun 1, 2012, 00:00

  • PCV43 Economic Burden of Venous Thromboembolism in Orthopedic Surgery Patients in Colombia

    Jun 1, 2012, 00:00

  • PDB71 Health Related Quality of Life in Kidney Transplant Patients With Diabetes

    Jun 1, 2012, 00:00

  • PRS35 Accessibility of the Copd Assessment Test (Cat) on Electronic Platforms for Wider Use among People Diagnosed with Copd

    Jun 1, 2012, 00:00

  • PCV76 Patient Factors Affecting Non-Adherence to Anticoagulation Therapy in an Inner-City Underserved Minority Population

    Jun 1, 2012, 00:00

  • PRS1 Assessing the Association of Omalizumab Use and Arteriothrombotic Events Through Spontaneous Adverse Event Reporting

    Jun 1, 2012, 00:00

  • PHP51 Review of the Clinical and Economic Value in the Use of Hybrid Operating Room

    Jun 1, 2012, 00:00

  • PDB91 Systematic Review of Diabetes Disease Management Inverventions

    Jun 1, 2012, 00:00

  • PIN28 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPSV23) Pneumococcal Vaccines for Adults in Colombia

    Jun 1, 2012, 00:00

  • PRS30 Inhaled Corticosteroid and Long-Acting Beta-Agonist Medication Compliance in Patients with Moderate and Severe Asthma

    Jun 1, 2012, 00:00

  • PND29 Resource Utilization and Caregiver Burden Associated With Fragile X Syndrome in the United States

    Jun 1, 2012, 00:00

  • PRM18 Review of Administration's Cost Assumption of Rotavirus and Pneumococcal Vaccines Cost-Effectiveness Analyses

    Jun 1, 2012, 00:00

  • PRM58 Turning the Implausible to the Plausible- Towards a Better Control of Over the Counter Dispensing of Antibiotics in Egypt

    Jun 1, 2012, 00:00

  • PND11 Cost of Cervical Dystonia in the United States

    Jun 1, 2012, 00:00

  • PIH48 Developing an Instrument to Assess Product Preference for Testosterone Replacement Therapy

    Jun 1, 2012, 00:00

  • PGI23 Cost Effectiveness of Retreatment of Patients with Chronic Hepatitis C (Chc) Who Do Not Respond to Peginterferon Alpha and Ribavirin for 48 Weeks Vs. Peginterferon Alfa and Ribavirin for 72 Weeks

    Jun 1, 2012, 00:00

  • PCN158 Projecting State Level Estimates for Rare Disease Using Census Data and Healthe Care Claims Database

    Jun 1, 2012, 00:00

  • PSU16 Retrospective Analysis of Cost Outcomes for Patients Receiving Infuse Bone Graft (rhBMP-2) or Actifuse Bone Graft Substitute (Si-CaP) During Posterolateral Spinal Fusion

    Jun 1, 2012, 00:00

  • PMH9 Description of the Burden Associated with Cognition Deficits in Schizophrenia

    Jun 1, 2012, 00:00

  • PHP62 Prescribing Evaluation Program in South Korea

    Jun 1, 2012, 00:00

  • PCN117 An Expert Panel Consensus on Medical Treatment of Non-Midgut Unresectable Neuroendocrine Tumors

    Jun 1, 2012, 00:00

  • PIN60 Epidemiology of Pneumococcal Diseases in Mexico in Patients Older Than 50 Years Old

    Jun 1, 2012, 00:00

  • PCN156 Development and Validation of a Patient-Reported Questionnaire to Assess the Quality of Life Outcomes of Indian Breast Cancer Patients

    Jun 1, 2012, 00:00

  • PMH59 Burden of Disease in Patients with Diagnosed Depression in Brazil- Results from 2011 National Health and Wellness Survey (NHWS)

    Jun 1, 2012, 00:00

  • MO3 Cost-Effectiveness Analysis of Different Strategies for Fragility Fracture Prevention in United States Male Veterans

    Jun 1, 2012, 00:00

  • PRM4 Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing- Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach

    Jun 1, 2012, 00:00

  • PMS62 Predictors of Health Related Quality of Life in a Cohort of Patients with Rheumatoid Arthritis in Southern India

    Jun 1, 2012, 00:00

  • PMS81 Factors Predicting Pain Medication Selection among Patients with Osteoarthritis

    Jun 1, 2012, 00:00

  • PHP10 Australia's Rule of Rescue and the Life Saving Drugs Programme- Same-Same But Different?

    Jun 1, 2012, 00:00

  • PSY17 Economic Burden Associated With Workplace Productivity Losses (WPL) in Patients With Psoriasis in a Population in the United States

    Jun 1, 2012, 00:00

  • PDB89 Real-World Management of Diabetes in Shanghai Minhang District

    Jun 1, 2012, 00:00

  • PCN69 Cost-Effectiveness Analysis of Aromatase Inhibitors and Tamoxifen As an Adjuvant Therapy in Postmenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

    Jun 1, 2012, 00:00

  • PHP2 Value of Patient Submissions in Drug Coverage Processes

    Jun 1, 2012, 00:00

  • PCV112 The Focus on Cardiovascular Drugs in Works of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011 As an Example of a Light Touch HTA Agency

    Jun 1, 2012, 00:00

  • PIH31 The Impact of Reducing Dosing Frequency of Oral Therapies on Adherence, Compliance, and Cost for Acute and Chronic Illnesses- A Meta-Analysis

    Jun 1, 2012, 00:00

  • Guide for Authors

    Jun 1, 2012, 00:00

  • PMH52 Levomilnacipran in the Treatment of Major Depressive Disorder- Functional Health and Well-Being Efficacy Results from a Phase III Clinical Trial

    Jun 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129 (current)
  • 130
  • »